Skip to main content

7 Result(s)

within Sang Kyun Sohn Remove this filter Pharmacology/Toxicology Remove this filter

and

  1. No Access

    Article

    Pilot study of adjuvant chemotherapy with 3-week combination of S-1 and cisplatin for patients with stage II-IV (M0) gastric cancer

    Purpose The feasibility of a 3-week combination of S-1 and cisplatin as an adjuvant chemotherapy for patients with curatively resected gastric cancer was investigated. Experimental design

    Byung Woog Kang, Jong Gwang Kim, Yee Soo Chae, Yoo ** Lee… in Investigational New Drugs (2012)

  2. No Access

    Article

    Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP

    Diffuse large B cell lymphoma (DLBCL) is a heterogenous disease entity due to diverse clinical outcomes to treatment. Most anticancer agents, regardless of their distinct mechanisms of action, ultimately kill ...

    Yee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn… in Cancer Chemotherapy and Pharmacology (2010)

  3. No Access

    Article

    Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin

    The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with colorectal cancer.

    Jong Gwang Kim, Yee Soo Chae, Sang Kyun Sohn… in Cancer Chemotherapy and Pharmacology (2009)

  4. No Access

    Article

    TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin

    The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer.

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2009)

  5. No Access

    Article

    Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer

    Since a weekly administration of paclitaxel has demonstrated a sustained efficacy and more favorable toxicity profile than a 3-weekly administration for various solid tumors, the present study was conducted to...

    Jong Gwang Kim, Sang Kyun Sohn, Hong Suk Song… in Cancer Chemotherapy and Pharmacology (2007)

  6. No Access

    Article

    Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study

    The present study was conducted to evaluate the safety and efficacy of alemtuzumab plus CHOP chemotherapy for patients with peripheral T-cell lymphomas (PTCLs).

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2007)

  7. No Access

    Article

    CHOP plus etoposide and gemcitabine (CHOP-EG) as front-line chemotherapy for patients with peripheral T cell lymphomas

    Objective: The present study evaluated the feasibility of CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) plus etoposide and gemcitabine (CHOP-EG) as front-line chemothe...

    Jong Gwang Kim, Sang Kyun Sohn, Yee Soo Chae… in Cancer Chemotherapy and Pharmacology (2006)